In Europe on Tuesday the FTSE Eurofirst 300 added 0.7 percent to 1,439.93, helped out by a strong start to the trading day in New York.
Stock exchanges were higher on the session. Deutsche Borse added 2.2 percent to €127.25 on an upgrade from “hold” to “add” by West LB. Even though the broker dropped its target price for Euronext while reiterating its “hold” recommendation, the pan-European exchange gained 2.3 percent to €87.30 after European regulators provisionally approved its takeover by NYSE Group.
Among airlines, Alitalia was 6.4 percent higher on an announcement from the Italian government that it will sell at least 30.1 percent of its stake in the airline. Italian law will require whoever buys the government stake to make a cash offer for the rest of the carrier.
In France, EDF gained 2.6 percent to €53.35 as it continued to reap benefits from a ruling last Friday that in practical terms meant that French rates for electricity are likely to rise.
The pharmaceuticals sector was up on news about diabetes drugs. Sanofi Aventis added 3 percent to €67.85 after it said a weight-loss drug, Acomplia, could also help in the treatment of type-2 diabetes. Meanwhile, Novo Nordisk gained 4.3 percent to DKr464.50 on its claim that a long-acting insulin, Levemir, both helped blood sugar levels in those with diabetes but also helped them lose weight.